SUPPLY AND DELIVERY OF MEDICAL SUPPLIES

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

U.S. EMBASSY MANILA

Contract Value

Not provided

Codes & Classification
Solicitation Number

19RP3826Q0059

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

PHILIPPINES

SourceSAM
Documents4
The U.S. Embassy in Manila, operating under the U.S. Department of State, issued a solicitation (Procurement Identifier: 19RP3826Q0059) for the supply and delivery of medical supplies in the Philippines. This procurement was classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505, indicating a focus on pharmaceutical products and related medical supplies. The primary objective of this procurement was to secure a reliable source for the timely supply and delivery of medical supplies to support the operational needs of the U.S. Embassy in Manila. The intended outcome was to establish a contract or purchase order with a responsible vendor capable of providing the required medical supplies at the lowest acceptable price, ensuring both quality and compliance with U.S. government standards. The solicitation process was structured as a Request for Quotations (RFQ), with clear instructions for submission. Offerors were required to submit their quotations electronically to [email protected], adhering to strict file format and size requirements (MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF, with each file not exceeding 10MB). Incomplete proposals or those not submitted in English were not considered. To be eligible for consideration, vendors needed to provide the following documentation: 1. Completed Standard Form 1449 (SF-1449) 2. Section I, Pricing 3. Section 5, Representations and Certifications 4. Additional information as specified in Section 3 of the solicitation 5. Proof of active registration in the System for Award Management (SAM) at https://www.sam.gov, as required by FAR 4.1102 The procurement process emphasized that award decisions would be made based on initial quotations, without discussions, unless deemed necessary for those within the competitive range. This approach underscored the importance of submitting a complete and competitive initial offer. The place of performance for this contract was the Philippines (Country Code: PHL), with all deliverables expected to be provided within this geographic area. The contracting entity was the U.S. Embassy Manila, a federal office under the Department of State. The primary and secondary points of contact for this solicitation were Sean Searcie and Kristine Grace C. Alcantara, both reachable at [email protected] or via phone at +63 2 5301 2000. The solicitation included a timeline for questions and submissions: all questions regarding the solicitation were to be submitted in writing by July 17, 2026, 4:00 PM Philippine local time, and final quotations were due by August 10, 2026, 4:00 PM Philippine local time. Late submissions were not accepted. It is important to note that, as of August 10, 2026, Amendment 002 was issued, resulting in the cancellation of this solicitation. Prior to cancellation, an earlier amendment (Amendment 001) had been released on August 7, 2026. This opportunity was not listed as a set-aside for small businesses or any other specific group, and no special considerations beyond SAM registration and compliance with submission requirements were indicated. For contractors evaluating this opportunity, the key requirements included demonstrated capability in pharmaceutical preparation manufacturing, compliance with U.S. government procurement standards, and the ability to deliver medical supplies within the Philippines. While the solicitation is now inactive and has been cancelled, the structure and requirements outlined provide valuable insight into the U.S. Embassy Manila’s procurement processes for similar future opportunities. Further details and official documentation related to this notice can be accessed via the SAM.gov opportunity ID e2c190f075d8427eb7d3cc161cff57b9 at https://sam.gov/opp/e2c190f075d8427eb7d3cc161cff57b9/view.